Items tagged with Guidelines
Latest Union guide for diagnosis and management of TB in children and adolescents launches (post)
9 February 2023: Today, the fourth edition of The Union’s desk guide for diagnosis and management of tuberculosis (TB) in children and adolescents has been published.
Screen for latent TB infection, USPSTF says (post)
The U.S. Preventive Services Task Force (USPSTF) said adults at increased risk for tuberculosis (TB) should still be screened for latent tuberculosis infection (LTBI).
WHO call for expressions of interest: Experts to conduct systematic reviews of the evidence on TB and undernutrition (post)
27 June 2023 | Geneva: WHO's Global Tuberculosis Programme has initiated a process to review the evidence on TB and nutrition to update the previous WHO guidelines: Nutritional care and support for patients with tuberculosis.
Experts identify clinical standards for adverse effects to TB treatment (post)
A panel of 65 global experts have identified eight clinical standards for the management of adverse effects during treatment for tuberculosis (TB).
Global prison TB surge exposes WHO guidelines gap (post)
Despite increasing TB rates in prisons across the globe, current World Health Organization (WHO) TB prevention guidelines fail to reach incarcerated populations. Programs should instead prioritize them, argue a group of researchers from a range of global institutions.
New operational guidance on adaptation and implementation of WHO's Multisectoral Accountability Framework to end TB (post)
20 September 2023 | New York The World Health Organization (WHO) has released Operational guidance for countries to support the adaptation and implementation of the Multisectoral Accountability Framework to end TB (MAF-TB). It provides practical advice on key approaches and interventions needed to establish the MAF-TB at the national and local levels with concrete country examples and best practices.
Standards for clinical trials for treating TB (post)
The value, speed of completion and robustness of the evidence generated by TB treatment clinical trials could be improved by implementing standards for best practice.
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C (post)
9 April 2024 — In a Rapid Communication issued today, the World Health Organization (WHO) is announcing updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C (HCV). The evidence suggests that concomitant treatment for HCV and multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) is feasible, with potential benefits outweighing the harms. Co-administration may increase MDR/RR-TB treatment success and reduce failures, losses to follow-up, and deaths. Adherence support for HCV treatment during MDR/RR-TB treatment is also acknowledged.
WHO #EndTB webinar: WHO guidance on conducting reviews of TB programs (post)
The World Health Organization (WHO) will host a global webinar on 5 June 2024 on its newly-released guidance on conducting reviews of TB programs and undertaking TB epidemiological reviews and assessments of TB surveillance and vital registration systems.
NHS England: Clinical commissioning policy statement for the treatment of drug-resistant TB (post)
The National Health Service (NHS) in England released Clinical commissioning policy statement, and accompanying documents, for the treatment for defined patients with rifampicin-resistant TB, multidrug-resistant TB, pre-extensively drug-resistant TB and extensively drug-resistant TB including bedaquiline and delamanid (all ages).
Page 9 of 16 · Total posts: 0
←First 8 9 10 Last→